| Trial ID: | L2796 |
| Source ID: | NCT00754689
|
| Associated Drug: |
Rimonabant
|
| Title: |
Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Rimonabant|DRUG: Metformin|DRUG: placebo
|
| Outcome Measures: |
Primary: Change from baseline in A1C, at 9 months | Secondary: Change from baseline in fasting plasma glucose, at 9 months|Change from baseline in body weight, at 9 months|Percent change from baseline in triglycerides, at 9 months|Percent change from baseline in HDL-C, at 9 months
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-09
|
| Completion Date: |
2008-11
|
| Results First Posted: |
|
| Last Update Posted: |
2016-05-17
|
| Locations: |
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, 08807, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00754689
|
